T1	Participants 401 426	494 boys entered on study
T2	Participants 55 83	acute lymphoblastic leukemia
T3	Participants 428 662	255 (51.6%) were in complete continuous remission (CCR) 3 years after entering remission and an additional eight were in CCR 3 years after localized extramedullary relapse and retreatment; 263 boys were eligible for testicular biopsy.
